MedPath

To see the effect of kanchnar guggulu and cystogrit diamond in stanagranthi (fibroadenoma breast)

Phase 2
Conditions
Health Condition 1: D249- Benign neoplasm of unspecified breast
Registration Number
CTRI/2023/09/057893
Lead Sponsor
Patanjali Ayurvedic College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Female patients having classical signs and symptoms of Stana Granthi is included viz. mobile lump in the breast and / or pain in the site of lump.

2. Patient fulfilling the diagnostic criteria of Stana Granthi i.e. investigation revealing presence of fibroadenoma breast.

3. Female patients will be selected between the age group of 15 – 45 years, irrespective of religion, occupation and economic status.

4. Female patients who are willing for trial.

Exclusion Criteria

1. Females of age below 15 years and above 45 years will be exclued.

2. Patients having history of severe systemic illness like Peptic ulcer, Inflammatory

Bowel Diseases, DM, HIV 1 & 2, HTN, Pregnancy, Crohn’s Disease, Ulcerative

Colitis, Malignancy & Tuberculosis will be excluded.

3. Participation in any other clinical trial during past 06 months.

4. Female patients not willing for trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subjective criteria <br/ ><br>Improvement in pain and consistency of fibroadenoma of breast <br/ ><br>Objective criteria <br/ ><br>Reduction in size and number of fibroadenoma of breastTimepoint: 0 day 30th day 60th day 90th day
Secondary Outcome Measures
NameTimeMethod
After follow up- 1. Any recurrences. <br/ ><br>2. Any Adverse Drug Reactions (ADR) will be noted and intimidated to ADR Department.Timepoint: 1 month
© Copyright 2025. All Rights Reserved by MedPath